“…Studies indicated a role of the HOGG1 Ser326Cys polymorphism in many cancers including oro-laryngeal cancer (Elahi et al, 2002;Yang et al, 2008), esophageal cancer (Xing et al, 2001), lung cancer (Lan et al, 2004), gastric cancer (Hanaoka et al, 2001), renal cell carcinoma (RCC) (Zhao et al, 2011), gallbladder cancer (Jiao et al, 2007), bladder cancer (Arizono et al, 2008), prostate cancer (Zhang et al, 2010) and acute lymphoblastic leukemia (Stanczyk et al, 2011).…”